neuroendocrine carcinoma

Showing 26 - 50 of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroendocrine Carcinoma Trial in France (FOLFOXIRI Protocol, Cisplatin injection)

Recruiting
  • Neuroendocrine Carcinoma
  • FOLFOXIRI Protocol
  • Cisplatin injection
  • Caen, France
  • +5 more
Apr 13, 2021

Neuroendocrine Carcinoma Trial in Italy (CPT-11, Calcio levofolinate, 5-Fluorouracil)

Recruiting
  • Neuroendocrine Carcinoma
  • Ancona, AN, Italy
  • +22 more
Feb 25, 2021

Neuroendocrine Carcinoma Trial in Beijing (Nab-paclitaxel Combined With Bevacizumab)

Recruiting
  • Neuroendocrine Carcinoma
  • Nab-paclitaxel Combined With Bevacizumab
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 9, 2021

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Temozolomide Trial in Seoul (TEMCAP)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Dec 13, 2020

Early Treatment Response in NEN (REBORN)

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Somatostatin analog; chemotherapy
  • Rome, Italy
    Andrea M Isidori
Dec 2, 2020

is to Demonstrat That Vacuum-assisted Closure Versus

Unknown status
  • Melanoma
  • +4 more
  • PREVENA
  • Nancy, France
    CHRU
Oct 6, 2020

Neuroendocrine Carcinoma Trial in Houston (68Ga-DOTATATE PET scan)

Completed
  • Neuroendocrine Carcinoma
  • 68Ga-DOTATATE PET scan
  • Houston, Texas
    Radio- Isotope Therapy of America
Oct 5, 2020

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Tumors Trial run by the NCI (Sunitinib, Everolimus)

Terminated
  • Neuroendocrine Tumors
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2020

Gastrointestinal Cancer, Neuroendocrine Carcinoma, Skin Cancer Trial in Columbus (Aromatherapy and Essential Oils, Subject

Completed
  • Gastrointestinal Cancer
  • +2 more
  • Aromatherapy and Essential Oils
  • Subject Diary
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 31, 2020

Neuroendocrine Carcinoma Trial in Toronto (Avelumab)

Completed
  • Neuroendocrine Carcinoma
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Mar 17, 2020

Neuroendocrine Carcinoma Trial in Italy (Everolimus)

Unknown status
  • Neuroendocrine Carcinoma
  • Modena, Emilia - Romagna, Italy
  • +4 more
Feb 20, 2020

Neuroendocrine Carcinoma Trial in Beijing (irinotecan cisplatin, Etoposide cisplatin)

Terminated
  • Neuroendocrine Carcinoma
  • irinotecan cisplatin
  • Etoposide cisplatin
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 19, 2020

Neuroendocrine Carcinoma Trial in Bergen (Everolimus , temozolomide)

Completed
  • Neuroendocrine Carcinoma
  • Everolimus , temozolomide
  • Bergen, Norway
    Haukeland University Hospital
Dec 18, 2019

Extensive Stage Small Cell Lung Carcinoma, Large Cell Lung Carcinoma, Neuroendocrine Carcinoma Trial in United States

Completed
  • Extensive Stage Small Cell Lung Carcinoma
  • +4 more
  • Loma Linda, California
  • +427 more
Jan 17, 2019

Neuroendocrine Carcinoma Trial in Beijing (SOX)

Unknown status
  • Neuroendocrine Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 10, 2017

Neuroendocrine Carcinoma Trial in Beijing (FOLFIRI Protocol)

Unknown status
  • Neuroendocrine Carcinoma
  • FOLFIRI Protocol
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 30, 2017

Neuroendocrine Carcinoma, Breast Cancer, Ovarian Cancer Trial in Copenhagen (Injection of 68Ga-NODAGA-E(c[RGDyK])2)

Unknown status
  • Neuroendocrine Carcinoma
  • +2 more
  • Injection of 68Ga-NODAGA-E(c[RGDyK])2
  • Copenhagen, Denmark
    Department of Clinical Physiology, Nuclear Medicine and PET, Rig
Nov 18, 2016

Neuroendocrine Carcinoma Trial in Nashville (68Ga-DOTATATE PET scan)

Completed
  • Neuroendocrine Carcinoma
  • 68Ga-DOTATATE PET scan
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Feb 25, 2016

Neuroendocrine Carcinoma Trial in United States (Bevacizumab, Pertuzumab, Sandostatin LARĀ® Depot)

Completed
  • Neuroendocrine Carcinoma
  • Fort Myers, Florida
  • +8 more
Jan 8, 2016

Neuroendocrine Carcinoma Trial in Tampa (Octreotide LAR)

Terminated
  • Neuroendocrine Carcinoma
  • Octreotide LAR
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 6, 2015

Neuroendocrine, Neuroendocrine Tumor, Neuroendocrine Cancer Trial in Kenner (68Ga-DOTATATE will be given in tracer doses and

Unknown status
  • Neuroendocrine
  • +7 more
  • 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography.
  • Kenner, Louisiana
    Ochsner Medical Center - Kenner
Jan 16, 2014

Neuroendocrine Carcinoma Trial in Houston (Avastin, RAD001)

Completed
  • Neuroendocrine Carcinoma
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
May 14, 2013

Merkel Cell Carcinoma, Islet Cell Carcinoma, Neuroendocrine Carcinoma Trial in Houston (antineoplaston A10, antineoplaston

Withdrawn
  • Merkel Cell Carcinoma
  • +3 more
  • antineoplaston A10
  • +7 more
  • Houston, Texas
    Burzynski Clinic
Jul 9, 2013

Carcinoma of Unknown Primary, Neuroendocrine Carcinoma, Neuroendocrine Carcinoma of the Skin Trial in New York (irinotecan HCl)

Completed
  • Carcinoma of Unknown Primary
  • +2 more
  • irinotecan hydrochloride
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 18, 2013

Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor Trial in Worldwide (Everolimus 10 mg, Octreotide Depot)

Completed
  • Islet Cell Carcinoma
  • +3 more
  • Everolimus 10 mg
  • Octreotide Depot
  • Birmingham, Alabama
  • +53 more
May 6, 2013